KEYWORD

cancer

Photo: CD8+ T cells (yellow) activated by PD-1 blockade also interact with T regulatory cells (teal and red), which subsequently dampen the immune response against the melanoma tumor cells (blue)

‘Cutting the cable’ between CD8+ T and T regulatory cells enhances checkpoint immunotherapy

Discovery by UC Irvine-led team may offer new strategy for improving melanoma treatment

A literal gut check

Scientist studies how intestinal microbiomes affect human health

Bridget Fortin, a UC Irvine doctoral student in the Department of Biological Chemistry (left) standing next to Selma Masri (right), UC Irvine associate professor of biological chemistry.

UC Irvine study reveals circadian clock can be leveraged to enhance cancer immunotherapy

Optimizing individual time-of-day delivery offers new avenues for prevention and treatment

Three men.

UC Irvine-led research team discovers role of key enzymes that drive cancer mutations

APOBEC3A and APOBEC3B offer potential new targets for intervention strategies

UC Irvine researchers awarded grants by the Chan Zuckerberg Initiative

Funding supports research into advanced biological tissue imaging technologies

Alexandre Chan, UCI chair and professor of clinical pharmacy practice

UC Irvine-led study links biomarkers and chemotherapy-related gastrointestinal symptoms

Predictors may offer new targets for pre-treatment therapeutic approaches

Franklin Dollar, assistant professor of physics and astronomy.

UC Irvine professor to help design the most powerful laser in the world

The NSF-funded effort would help the U.S. to reclaim lead in laser technology

UCI awarded $2.4 million grant to study potential treatment for cancer-related cognitive impairment

Study to evaluate potential treatment approach for ‘chemobrain’

David Richardson, UCI Professor, Environmental and Occupational Health.

UC Irvine-led study links low-dose radiation to higher cancer risk

Caution warranted given increased public exposure in recent decades

Photo of Anai Campos Contreras

Anai Campos Contreras named 2023 Pew Latin American Fellow in the Biomedical Sciences

The Pew Charitable Trusts has named Anai Campos Contreras, incoming UC Irvine postdoctoral fellow in pharmacy and pharmaceutical sciences, a 2023 Pew Latin American Fellow in the Biomedical Sciences. Campos received a Ph.D. in biomedical sciences in 2022 from the National Autonomous University of Mexico. Later this summer, she will join the laboratory of Thomas Martinez, […]